Patients with deadly form of lung cancer lived longer without disease worsening
5 June 2011 | By Eli Lilly and Company
Eli Lilly and Company announced that PARAMOUNT, met its primary endpoint of progression-free survival...
List view / Grid view
News
Second Phase 3 Study of YERVOY™ (ipilimumab) in Metastatic Melanoma Meets Primary Endpoint of Overall Survival
5 June 2011 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (NYSE: BMY) today announced results from a second Phase 3 randomized, double blind study...
Roche announces vemurafenib improved survival in people with metastatic melanoma who have BRAF V600 mutations
5 June 2011 | By Roche
Roche announced that a Phase III study (BRIM3) showed vemurafenib (RG7204, PLX4032) significantly improved overall survival in people with previously untreated BRAF V600 mutation...
Roche announces data to show Avastin based regimen halved the risk of disease getting worse in women with recurrent ovarian cancer
4 June 2011 | By Roche
Roche announced results from OCEANS, a phase III study evaluating Avastin (bevacizumab) in combination with chemotherapy (gemcitabine and carboplatin)...
Late-breaking ASCO data demonstrate circulating tumor cells as potential biomarker for metastatic prostate cancer clinical trials
4 June 2011 | By Johnson & Johnson
This study represents the first randomized, double-blind, placebo controlled Phase III trial to evaluate CTCs as a potential biomarker for overall survival...
GlaxoSmithKline’s pazopanib improved progression free survival in adults with certain soft tissue sarcomas
4 June 2011 | By GlaxoSmithKline
Results of the PALETTE study presented at the 2011 Annual Meeting of the ASCO...
Thermo Fisher Scientific debuts fastest, more sensitive ion trap mass spectrometer
Thermo Fisher Scientific Inc., the world leader in serving science, today announced fundamentally redefined ion trap mass spectrometer capabilities with the introduction of its new dual-pressure linear ion trap system, the Thermo Scientific Velos Pro.
Thermo Fisher Scientific introduces new high-field Orbitrap Mass Spectrometer
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced a new milestone in Orbitrap technology, the Thermo Scientific Orbitrap Elite.
Pfizer and Hisun sign MOU to increase access to quality and low-cost medicines for patients in China
2 June 2011 | By
Pfizer Inc. and Zhejiang Hisun Pharmaceuticals jointly announced the signing of a MOU on their intention to establish a joint venture...
Thermo Fisher Scientific debuts high-performance benchtop quadrupole-Orbitrap mass spectrometer
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific Q Exactive high-performance benchtop quadrupole-Orbitrap LC-MS/MS. It is the first commercially available instrument to bring together quadrupole precursor selection and high-resolution accurate mass (HR/AM) Orbitrap mass analysis to deliver high confidence quantitative and qualitative (quan/qual)…
Health Canada approves BRILINTA (ticagrelor tablets)
1 June 2011 | By AstraZeneca
AstraZeneca announced that Health Canada has approved BRILINTA (ticagrelor tablets)...
AstraZeneca and Heptares collaborate to investigate important GPCR drug targets
31 May 2011 | By AstraZeneca
AstraZeneca & Heptares entered a four-year collaboration focused on the potential discovery & development of new medicines...
ICON Selected by Pfizer as a Global Strategic Partner for Clinical Research and Development
26 May 2011 | By ICON plc
ICON plc has announced a strategic partnership with Pfizer Inc...
Data supports efficacy of XIAPEX® (collagenase clostridium histolyticum)
26 May 2011 | By red healthcare communications
Data presented for the first time at the annual congress of the FESSH, further supports the role of XIAPEX®...
Tecan offers complete automation for cell-based screening
26 May 2011 | By kdm communications limited
Tecan has launched Tecan Sterile purity disposable tips for the Freedom EVO® liquid handling (LiHa) arm...
